Deutsche Bank
ACTU

Deutsche Bank’s Actuate Therapeutics ACTU Stock Holding History

Deutsche Bank’s Portfolio ACTU Stock Details ACTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.7K Sell
12,235
-24,163
-66% -$56K ﹤0.01% 3611
2026
Q1 		$99.7K Buy
36,398
+27,089
+291% +$112K ﹤0.01% 3282
2025
Q4 		$57K Buy
9,309
+8,051
+640% +$55.3K ﹤0.01% 3430
2025
Q3 		$8.42K Sell
1,258
-9,181
-88% -$66.6K ﹤0.01% 3525
2025
Q2 		$63.8K Buy
+10,439
New +$91.2K ﹤0.01% 3381

Other funds holding ACTU

BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.87B AUM 24.49% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $306M AUM 15.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ADEF
ABS Direct Equity Fund Stamford, Connecticut $159M AUM 34.17% 1-Year Est. Return

Deutsche Bank's ACTU Position: Q2 2026 in Review

Deutsche Bank reduced its Actuate Therapeutics (ACTU) stake by 66% in Q2 2026, selling an estimated $56K and leaving 12,235 shares worth $18.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3611.

Deutsche Bank first reported a position in ACTU in Q2 2025 and has held it in 5 quarters since. The position peaked at $99.7K in Q1 2026. 63 funds tracked by Wall St. Rank hold ACTU as of Q2 2026.

  • Deutsche Bank held 12,235 shares of Actuate Therapeutics worth $18.7K as of Q2 2026.
  • Deutsche Bank sold 24,163 Actuate Therapeutics shares in Q2 2026, an estimated $56K.
  • Actuate Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #3611 holding.
  • Deutsche Bank first reported a position in Actuate Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Deutsche Bank's Actuate Therapeutics position peaked at $99.7K in Q1 2026.
  • 63 funds tracked by Wall St. Rank held Actuate Therapeutics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.